Cardiocranial syndrome, Pfeiffer type

From WikiMD's WELLNESSPEDIA


Cardiocranial syndrome, Pfeiffer type
Synonyms Pfeiffer syndrome
Pronounce N/A
Specialty N/A
Symptoms Craniosynostosis, broad thumbs, broad toes, partial soft tissue syndactyly
Complications Hearing loss, dental problems, vision problems
Onset Congenital
Duration Lifelong
Types N/A
Causes Genetic mutation in the FGFR1 or FGFR2 genes
Risks Family history
Diagnosis Clinical examination, genetic testing
Differential diagnosis Apert syndrome, Crouzon syndrome, Saethre-Chotzen syndrome
Prevention Genetic counseling
Treatment Surgical intervention, physical therapy, occupational therapy
Medication Symptomatic treatment
Prognosis Varies, depending on severity
Frequency 1 in 100,000 births
Deaths N/A


Cardiocranial syndrome, Pfeiffer type is a rare genetic disorder characterized by specific abnormalities of the skull, hands, feet, and heart. It is a subtype of Pfeiffer syndrome, which is a broader category of craniosynostosis syndromes.

Overview[edit]

Cardiocranial syndrome, Pfeiffer type, is a condition that primarily affects the development of the bones in the skull, hands, and feet, as well as the heart. The syndrome is named after the German geneticist Rudolf Pfeiffer, who first described it in 1964. It is a rare disorder, with only a few reported cases worldwide.

Symptoms[edit]

The most common symptoms of Cardiocranial syndrome, Pfeiffer type, include craniosynostosis, which is the premature fusion of the skull bones, leading to an abnormal head shape. Other symptoms include broad and deviated thumbs and big toes, short stature, and heart defects. Some individuals may also have mild to moderate intellectual disability.

Causes[edit]

Cardiocranial syndrome, Pfeiffer type, is caused by mutations in the FGFR1 or FGFR2 genes. These genes provide instructions for making proteins that are involved in the development and maintenance of bone and brain tissue.

Diagnosis[edit]

Diagnosis of Cardiocranial syndrome, Pfeiffer type, is based on the presence of characteristic clinical features. Genetic testing can confirm the diagnosis by identifying mutations in the FGFR1 or FGFR2 genes.

Treatment[edit]

Treatment for Cardiocranial syndrome, Pfeiffer type, is symptomatic and supportive. It may include surgery to correct craniosynostosis and heart defects, physical therapy for hand and foot abnormalities, and educational support for those with intellectual disability.

See also[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.